Open AccessThe use of Jelonet dressings in the treatment of drug toxicity in autologous stem cell transplantation in children. Clinical case presentation
Author(s) -
Т. З. Алиев,
Т. С. Белышева,
К. А. Сергеенко,
Е. Б. Мачнева,
Н. В. Сидорова,
Т. Т. Валиев,
И. О. Костарева,
К. И. Киргизов
Publication year - 2021
Publication title -
rossijskij žurnal detskoj gematologii i onkologii
Language(s) - English
Resource type - Journals
eISSN - 2413-5496
pISSN - 2311-1267
DOI - 10.21682/2311-1267-2021-8-3-97-101
Subject(s) - treosulfan , medicine , hematopoietic stem cell transplantation , surgery , presentation (obstetrics) , stem cell , complication , transplantation , toxicity , drug toxicity , dermatology , biology , genetics , busulfan
One of the complications arising at the stage of hematopoietic stem cell transplantation (HSCT) is skin lesions. This complication is quite common and represents an important diagnostic and therapeutic problem. The main cause of skin lesions in HSCT is drug toxicity, but also infectious lesions. Each of the complications can manifest itself in varying degrees, as well as be combined with others, having a significant negative effect on the patient’s condition, in severe cases posing a threat to the patient’s life. This paper presents a clinical case of a patient with treosulfan toxicoderma who was treated with JELONET dressings.